226 related articles for article (PubMed ID: 26616677)
21. Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles.
Matuszak J; Lutz B; Sekita A; Zaloga J; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2018; 13():8443-8460. PubMed ID: 30587970
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis.
Moreno JA; Ortega-Gómez A; Delbosc S; Beaufort N; Sorbets E; Louedec L; Esposito-Farèse M; Tubach F; Nicoletti A; Steg PG; Michel JB; Feldman L; Meilhac O
Eur Heart J; 2012 Jan; 33(2):252-63. PubMed ID: 21606088
[TBL] [Abstract][Full Text] [Related]
23. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
[TBL] [Abstract][Full Text] [Related]
24. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.
Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777
[TBL] [Abstract][Full Text] [Related]
25. Intravascular ultrasound predictors of CD163 positive macrophage infiltration.
Sato T; Kameyama T; Ueno H; Inoue H
J Interv Cardiol; 2014 Jun; 27(3):317-24. PubMed ID: 24612144
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
27. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
29. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
30. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice.
Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G
PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S; Schnorr J; Ludwig A; Stangl V; Ebert M; Hamm B; Taupitz M
Int J Nanomedicine; 2013; 8():767-79. PubMed ID: 23450179
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
33. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
[TBL] [Abstract][Full Text] [Related]
34. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.
Maniecki MB; Møller HJ; Moestrup SK; Møller BK
Immunobiology; 2006; 211(6-8):407-17. PubMed ID: 16920480
[TBL] [Abstract][Full Text] [Related]
35. The macrophage scavenger receptor CD163.
Fabriek BO; Dijkstra CD; van den Berg TK
Immunobiology; 2005; 210(2-4):153-60. PubMed ID: 16164022
[TBL] [Abstract][Full Text] [Related]
36. CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis.
Silva RA; Giordano RJ; Gutierrez PS; Rocha VZ; Rudnicki M; Kee P; Abdalla DS; Puech-Leão P; Caramelli B; Arap W; Pasqualini R; Meneghetti JC; Marques FL; Khoobchandani M; Katti KV; Lugão AB; Kalil J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563889
[TBL] [Abstract][Full Text] [Related]
37. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles.
Wang Y; Chen J; Yang B; Qiao H; Gao L; Su T; Ma S; Zhang X; Li X; Liu G; Cao J; Chen X; Chen Y; Cao F
Theranostics; 2016; 6(2):272-86. PubMed ID: 26877785
[TBL] [Abstract][Full Text] [Related]
38. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe
Qiao H; Wang Y; Zhang R; Gao Q; Liang X; Gao L; Jiang Z; Qiao R; Han D; Zhang Y; Qiu Y; Tian J; Gao M; Cao F
Biomaterials; 2017 Jan; 112():336-345. PubMed ID: 27788352
[TBL] [Abstract][Full Text] [Related]
39. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
40. CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow.
Fischer-Riepe L; Daber N; Schulte-Schrepping J; Véras De Carvalho BC; Russo A; Pohlen M; Fischer J; Chasan AI; Wolf M; Ulas T; Glander S; Schulz C; Skryabin B; Wollbrink Dipl-Ing A; Steingraeber N; Stremmel C; Koehle M; Gärtner F; Vettorazzi S; Holzinger D; Gross J; Rosenbauer F; Stoll M; Niemann S; Tuckermann J; Schultze JL; Roth J; Barczyk-Kahlert K
J Allergy Clin Immunol; 2020 Nov; 146(5):1137-1151. PubMed ID: 32199911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
